2007 JASN IMPACT FACTOR 7.111	HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP
advanced	CURRENT ISSUE	ARCHIVES	JASN Express	ONLINE SUBMISSION

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fischer, P. A. Articles by Masnatta, L. D. Search for Related Content PubMed PubMed Citation Articles by Fischer, P. A. Articles by Masnatta, L. D.

Hyperhomocysteinemia Induces Renal Hemodynamic Dysfunction: Is Nitric Oxide Involved?

Patricia A. Fischer^*, Graciela N. Dominguez^*, Luis A. Cuniberti, Verónica Martinez, José P. Werba, Agustín J. Ramirez^* and Lucas D. Masnatta^*

*Section of Pharmacology, Department of Physiology, and Lipid and Atherosclerosis Research Laboratory, Department of Pathology, Favaloro University, Buenos Aires, Argentina.

Correspondence to Lucas Daniel Masnatta, Section of Pharmacology, Department of Physiology, Favaloro University, Solís 453, Buenos Aires (C1078AAI), Argentina. Phone/Fax: 5411-4-383-9744;

ABSTRACT. Hyperhomocysteinemia is associated with endothelial dysfunction, although the underlying mechanism is unknown. Previous studies have shown that nitric oxide (NO) plays an important role in the regulation of systemic and renal hemodynamics. This study investigated whether hyperhomocysteinemia induces renal oxidative stress and promotes renal dysfunction involving disturbances of the NO-pathway in Wistar rats. During 8 wk, control (C) and hyperhomocysteinemic (HYC) groups had free access to tap water and homocysteine-thiolactone (HTL, 50 mg/kg per d), respectively. At 8 wk, plasma homocysteine concentration, renal superoxide anion (O₂), nitrotyrosine, and nitrite+nitrate levels, and renal function were measured. To assess NO involvement, the responses to L-Arginine (L-Arg, 300 mg/kg) and N^G-nitro-L-arginine-methyl-ester (L-NAME, 20 µg/kg per min for 60 min) were analyzed. The HYC group showed higher homocysteine concentration (7.6 ± 1.7 versus 4.9 ± 1.0 µmol/L; P < 0.001), (O₂; production (157.92 ± 74.46 versus 91.17 ± 29.03 cpm · 10³/mg protein), and nitrite+nitrate levels (33.4 ± 5.1 versus 11.7 ± 4.3 µmol/mg protein; P < 0.001) than the control group. Western blot analyses showed a nitrotyrosine mass 46% higher in the HYC group than in the controls. Furthermore, the HYC group showed lower GFR, renal plasma flow (RPF), and higher renal vascular resistance (RVR) than the controls. After L-Arg administration, the responses of GFR, RPF, and RVR were attenuated by 36%, 40%, and 50%, respectively; after L-NAME, the responses of RPF and RVR were exaggerated by 79% and 112%, respectively. This suggests a reduced NO bioavailability to produce vasodilation and an enhanced sensitivity to NO inhibition. In conclusion, hyperhomocysteinemia induces oxidative stress, NO inactivation, and renal dysfunction involving disturbances on the NO-pathway. E-Mail: masnatta@favaloro.edu.ar

This article has been cited by other articles:

				G. A. Prathapasinghe, Y. L. Siow, Z. Xu, and K. O Inhibition of cystathionine-{beta}-synthase activity during renal ischemia-reperfusion: role of pH and nitric oxide Am J Physiol Renal Physiol, October 1, 2008; 295(4): F912 - F922. [Abstract] [Full Text] [PDF]

				M. Kerkeni, F. Addad, M. Chauffert, A. Myara, M. Ben Farhat, A. Miled, K. Maaroufi, and F. Trivin Hyperhomocysteinemia, Endothelial Nitric Oxide Synthase Polymorphism, and Risk of Coronary Artery Disease Clin. Chem., January 1, 2006; 52(1): 53 - 58. [Abstract] [Full Text] [PDF]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673